Exploring the Application Value of New Magnetic Resonance Imaging Technologies in Non-invasive Quantitative Assessment of Graft Function After Liver Transplantation
Launched by ZHEN LI · May 25, 2025
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Title: Exploration of New Magnetic Resonance Imaging Technologies for Non-invasive Quantitative Assessment of Graft Function after Liver Transplantation
Principal Investigator: Professor Li Zhen
Research Institution: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Objective:
The study aims to explore the value of new imaging technologies in assessing the early postoperative graft function in liver transplant patients. It seeks to establish relationships between imaging parameters, body composition, metabolic diseases, and graft function, with the g...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients who have undergone liver transplantation.
- • 2. Patients who are scheduled for MR imaging post-transplant.
- • 3. Voluntary participation with signed informed consent.
- Exclusion Criteria:
- • 1. Patients with contraindications for MRI, such as pacemakers, unknown metallic implants, or neurostimulators.
- • 2. Patients with claustrophobia or inability to tolerate the required breath-holds for MRI.
- • 3. Patients who cannot comply with the study requirements.
About Zhen Li
Zhen Li is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on conducting rigorous and ethically sound clinical trials, Zhen Li collaborates with leading researchers and healthcare institutions to evaluate the safety and efficacy of novel treatments. The organization emphasizes transparency, compliance, and integrity throughout the research process, ensuring that all trials are designed and executed to the highest standards. By fostering partnerships and leveraging cutting-edge methodologies, Zhen Li aims to contribute significantly to the scientific community and enhance the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported